PSMA-PET total tumour volume is prognostic for overall survival in mCRPC. thelancet.com/journals/lanon… PSMA-PET value extends beyond selection for PSMA-RLT therapy in metastatic prostate cancer. urotoday.com/video-lectures… ANZUP @trialscentre Prostate Cancer Foundation Movember Australia

Access the full paper on PSMA-PET prognostic and predictive biomarkers in ENZAp with the link below: ANZUP LancetOncology NHMRC CTC Movember Australia Prostate Cancer Foundation authors.elsevier.com/a/1lWie5EIIgTS…

🔥 RTOG 9601 – Long-Term Data Just Dropped! OncoAlert 📌 Salvage RT with vs. without Anti-Androgen Therapy (AAT) in men with post-prostatectomy recurrence (PSA 0.2–4.0, pT2/3N0) 💊 24 months of bicalutamide 150 mg during & after RT 🎯 18-Year Outcomes (n=760): • 🧬 Overall

Summary key results !

Two interesting facts 1) The authors of the 2015 phIII SpaceOAR paper (crucial for FDA approval) received $830K from Augmenix/Boston Scientific openpaymentsdata.cms.gov AND 2) There've been ~165 MAUDE adverse reports re: SpaceOAR in 2025 alone(!) accessdata.fda.gov/scripts/cdrh/c…

Excellent editorial on the DADSPORT meta-analysis: sciencedirect.com/science/articl…

📢 MRI-led active surveillance for #ProstateCancer in 1150 men: 🧠 2 in 3 avoided biopsy at 5y 📉 91% EFS in MRI-invisible Gleason 3+3 ⚠️ Only 5% progressed to ≥Gleason 4+3 📚 Published in European Urology 🔗buff.ly/elyj2IG #UroTwitter #MRI #Urology #PCa

Salvage lymph node dissection for PSMA+ #ProstateCancer Radioguidance: super cool tech Results, overall: not as impressive 2y BCR-free survival 18-30%. And 26-30% of pts had zero positive nodes. Conclusions: ▶️Avoid salvage LND ▶️Don't believe everything you see on PSMA PET

Excited to share our study Tumor transcriptome-wide expression classifiers predict treatment sensitivity in advanced prostate cancer Emily Grist Marina Parry MRC Clinical Trials Unit at UCL UCL Cancer Institute Prostate Cancer UK Prostate Cancer Foundation Nick James also on @Prof-Nick-James.bsky.social Tamara Lotan, MD Decipher by Veracyte Christopher Sweeney, MBBS sciencedirect.com/science/articl…

Prostate tumours classified as high Decipher and PTEN inactive have a 45% reduction in hazard of death when Doce is added to ADT. This biomarker should be tested in pts considered for triplet therapy.

You can also read about our findings in The Times and The Sunday Times thetimes.com/uk/healthcare/…

🚨New Simply Oncology Podcast Out 28.8.25 Calling all #ProstateCancer We discuss the challenges of managing patients with rising PSA after prostatectomy. We talk to the excellent Chris Parker who has led the RADICALS trial. Simply Oncology European Urology The ICR ProstateCancerResearch

Every #radiologist probably has a secret ambition to have something named after them, Dr Giles Maskell says. In a new column, he introduces Maskell's Law of #Cancer. buff.ly/KQEu1Ax #radiology

Another proof that metastasis directed therapy improves outcomes, this time in castration resistant #prostatecancer Congrats to the PCS IX team! author link at The Lancet Oncology: authors.elsevier.com/a/1liJQ5EIIgTS…

Read about our latest publication in The Lancet Oncology from Common Sense Oncology RCT team re responder criteria for measuring QOL in clinical trials for advanced cancer.

A brilliant column by Giles. Well worth 5 minutes of your time

A European history of prostate cancer radiotherapy, with gratitude to the always amazing Prof David Dearnaley 📚 Bedtime reading for #Prostate radoncs: oncopedia.wiki/contributions/… The Royal Marsden NHS Foundation Trust The ICR ESOncology #ProstateCancer

This is big! Worked with great statisticians on guidelines for meta-analysis & systematic review. We discuss rationales for systematic review, evaluation & interpretation of heterogeneity, & common errors in network meta-analysis, funnel plots etc. europeanurology.com/article/S0302-…

One of the biggest influences on my career is Dr. Ross Camidge - a mentor and friend, an intellectual giant in the field of lung cancer who was diagnosed with this unforgiving disease himself. We are all at risk - and must all work to move the field. news.cuanschutz.edu/cancer-center/…

ICYMI 👇 our latest study Tumor transcriptome-wide expression classifiers predict treatment sensitivity in advanced prostate cancer sciencedirect.com/science/articl… Please share!